How many studies have been conducted on Gastric Inhibitory Polypeptide?

BiohacksAI has indexed 300 PubMed studies on Gastric Inhibitory Polypeptide, including 7 randomized controlled trials (RCTs). 33% of studies involve human subjects.

What are the main research areas for Gastric Inhibitory Polypeptide?

The primary research domains for Gastric Inhibitory Polypeptide are 🔥 Metabolic, 🦠 Gut & Microbiome, 🧬 Hormones. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Gastric Inhibitory Polypeptide

A gastrointestinal peptide hormone of about 43-amino acids. It is found to be a potent stimulator of INSULIN secretion and a relatively poor inhibitor of GASTRIC ACID secretion.

300+ PubMed studies analyzed · 7 RCTs · Evidence Score: 50.5

Research Domains

Gastric Inhibitory Polypeptide has been studied across 16 research domains including 🔥 Metabolic, 🦠 Gut & Microbiome, 🧬 Hormones, 🔬 Oncology, 😴 Sleep. The primary research focus is 🔥 Metabolic with 66% of studies addressing this area.

Loading evidence profile...

This evidence profile for Gastric Inhibitory Polypeptide is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.